Literature DB >> 12823585

A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy.

Tobias Leniger1, Colette Kananura, Andreas Hufnagel, Sonia Bertrand, Daniel Bertrand, Ortrud K Steinlein.   

Abstract

PURPOSE: To identify and characterize the mutation(s) causing nocturnal frontal lobe epilepsy in a German extended family.
METHODS: Neuronal nicotinic acetylcholine receptor (nAChR) subunit genes were screened by direct sequencing. Once a CHRNA4 mutation was identified, its biophysical and pharmacologic properties were characterized by expression experiments in Xenopus oocytes.
RESULTS: We report a new CHRNA4 mutation, causing a alpha4-T265I amino acid exchange at the extracellular end of the second transmembrane domain (TM). Functional studies of alpha4-T265I revealed an increased ACh sensitivity of the mutated receptors. alpha4-T265I is associated with an unusual low penetrance of the epilepsy phenotype. Sequencing of the TM1-TM3 parts of the 1 known nAChR subunits did not support a two-locus model involving a second nAChR sequence variation.
CONCLUSIONS: nAChR mutations found in familial epilepsy are not always associated with an autosomal dominant mode of inheritance. alpha4-T265I is the first nAChR allele showing a markedly reduced penetrance consistent with a major gene effect. The low penetrance of the mutation is probably caused by unknown genetic or environmental factors or both.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12823585     DOI: 10.1046/j.1528-1157.2003.61102.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  17 in total

Review 1.  Autosomal dominant nocturnal frontal lobe epilepsy--a critical overview.

Authors:  Romina Combi; Leda Dalprà; Maria Luisa Tenchini; Luigi Ferini-Strambi
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

2.  Mutational analysis of CHRNB2, CHRNA2 and CHRNA4 genes in Chinese population with autosomal dominant nocturnal frontal lobe epilepsy.

Authors:  Zhihong Chen; Lingan Wang; Chun Wang; Qian Chen; Qiongxiang Zhai; Yuxiong Guo; Yuxin Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 3.  Nocturnal frontal lobe epilepsy.

Authors:  Lino Nobili; Paola Proserpio; Romina Combi; Federica Provini; Giuseppe Plazzi; Francesca Bisulli; Laura Tassi; Paolo Tinuper
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

Review 4.  The sleep manifestations of frontal lobe epilepsy.

Authors:  Christopher P Derry
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

Review 5.  Paroxysmal Movement Disorders: Recent Advances.

Authors:  Zheyu Xu; Che-Kang Lim; Louis C S Tan; Eng-King Tan
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-11       Impact factor: 5.081

Review 6.  Ion Channel Genes and Epilepsy: Functional Alteration, Pathogenic Potential, and Mechanism of Epilepsy.

Authors:  Feng Wei; Li-Min Yan; Tao Su; Na He; Zhi-Jian Lin; Jie Wang; Yi-Wu Shi; Yong-Hong Yi; Wei-Ping Liao
Journal:  Neurosci Bull       Date:  2017-05-09       Impact factor: 5.203

7.  Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy.

Authors:  Alwin Klaassen; Joseph Glykys; Jamie Maguire; Cesar Labarca; Istvan Mody; Jim Boulter
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-04       Impact factor: 11.205

Review 8.  Nicotinic receptor channelopathies and epilepsy.

Authors:  Ortrud K Steinlein; Daniel Bertrand
Journal:  Pflugers Arch       Date:  2009-12-17       Impact factor: 3.657

9.  Altered activity-rest patterns in mice with a human autosomal-dominant nocturnal frontal lobe epilepsy mutation in the β2 nicotinic receptor.

Authors:  J Xu; B N Cohen; Y Zhu; G Dziewczapolski; S Panda; H A Lester; S F Heinemann; A Contractor
Journal:  Mol Psychiatry       Date:  2010-07-06       Impact factor: 15.992

Review 10.  The possible contribution of neuronal nicotinic acetylcholine receptors in depression.

Authors:  Daniel Bertrand
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.